Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus

BACKGROUND: Metformin is a first-line drug in type 2 diabetes mellitus (T2DM) treatment, yet whether metformin may increase all-cause or cardiovascular mortality of T2DM patients remains inconclusive. METHODS: We searched PubMed and Embase for data extracted from inception to July 14, 2020, with a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tian, Providencia, Rui, Mu, Nan, Yin, Yue, Chen, Mai, Wang, Yishi, Liu, Manling, Yu, Lu, Gu, Chunhu, Ma, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847575/
https://www.ncbi.nlm.nih.gov/pubmed/33516224
http://dx.doi.org/10.1186/s12933-020-01202-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847575/
https://www.ncbi.nlm.nih.gov/pubmed/33516224
http://dx.doi.org/10.1186/s12933-020-01202-5

Ejemplares similares